Lessons from Real-World Device Testing

Paul Charlebois and Eric Olson are seated across from each other at a white table in a modern office setting. The man on the left has curly brown hair and is wearing a light blue button-up shirt. He is smiling and looking toward the man on the right, who has short gray hair, glasses, and is wearing a dark patterned shirt with a small microphone clipped to his collar. The background is a bright, blurred open-plan office with desks and chairs, creating a soft focus effect behind the subjects. A blue pen and a blurred stack of folders or documents are on the table in the foreground.
Resources

Lessons from Real-World Device Testing

YouTube video thumbnail

In this episode of Before the Build, Eric Olson and Paul Charlebois explore the unpredictable nature of real-world device testing. Even the best-designed devices, prepared with careful simulations and usability studies, can behave very differently when used in actual clinical or emergency situations.

Eric opens by reflecting on the limits of design planning. Teams work hard to understand workflows, but sometimes no amount of mockups or lab testing can replicate the stress, urgency, or unpredictability of real life. Paul recalls a neurosurgery case where a circulating nurse struggled with a specialized cutting device. In the dark, under pressure from the surgical team, she had to fumble with instructions while the surgeon demanded immediate action. The moment highlighted how hard it is to simulate stress during usability studies and raised important questions about testing devices under realistic conditions.

When Training Meets Reality

Eric and Paul share additional examples, such as automatic external defibrillators (AEDs). These life-saving devices are designed for simple bystander use with clear prompts and automation. Yet in practice, many AEDs end up locked in cabinets, hidden from view, or only known to a few trained employees. The gap between intended usability and real-world access shows the importance of considering full context during real-world device testing.

Another observation came from an epidural case. The anesthesiologist expected a straightforward procedure with a cooperative nurse as the patient. Instead, the situation turned chaotic when emotions ran high, leaving the researchers to realize how quickly assumptions can collapse. These moments, while unplanned, create some of the most valuable insights for improving device design.

Why Unpredictability Improves Design

As Paul notes, what feels like an “edge case” may actually reveal critical lessons. Unexpected reactions and stressful environments expose hidden design flaws and usability challenges. Ultimately, testing devices in real-world conditions helps teams create safer, more effective solutions that perform in both calm and chaotic situations.

Watch now to hear Eric and Paul discuss the stories that shaped their understanding of how unpredictable use can drive better MedTech design.

Gloved hands insert a swab into a sealed vial beside a crossed-out O₂ symbol with the text “No Oxygen Allowed?” illustrating anaerobic sample collection.

Nick Allan joins Nigel Syrotuck to explore how anaerobic sample collection works and why it’s vital for studying bacteria that cannot survive in oxygen.

icons representing different medical device classes

Understanding medical device classifications is critical for compliance, risk management, and time-to-market success. Whether you’re designing a wearable sensor or a life-sustaining implant, knowing how your device fits into FDA Class 1, 2, or 3 categories is essential.

Delivering a drug to the right place at the right time can define the success of a therapy. Yet understanding delivery routes, devices, and technologies across the body can be complex.

Cover of the free StarFish Medical guide “Drug Delivery Decisions,” featuring a gradient design with wave patterns, offering insights on drug-device combination product strategy.

This in-depth drug delivery strategy guide from StarFish Medical explores how to design, develop, and deliver breakthrough drug-device combination products.